Navigation
Navigation
User login
Back to top

The Haematological Malignancy Research Network provides information about leukaemias, lymphomas, myelomas, and related blood disorders. Our statistics are based on data from the UK, and use the World Health Organization’s Classification for Oncology (ICD-O-3) which currently recognises over 100 different haematological malignancy subtypes.

If you are a participant in our research, you can find more information on our patient hub, YHHN.org.

What's new?

Updated statistics

We have updated our statistics to include patients diagnosed between January 1st 2010 and 31st December 2019, with follow-up for mortality up to 1st September 2022. Our survival methodology has now been updated to calculate net survival. Find out more on our methods page.

Please contact us if you have any questions about this update or require access to previous versions of the data.

12th October 2022

Recent collaborations

HMRN data was used in this research

Longitudinal expression profiling identifies a poor risk subset of patients with ABC-type Diffuse Large B Cell Lymphoma, Blood Advances, August 2022

Read it here

Network members

NHS haematology staff in the HMRN clinical network can access the Members' section here (active HMRN account required)

Visit members' section